Gestational birth age is strongly correlated with central macular thickness

Article

Prematurely born children have a thicker central macular than children born at term

A recent study featured in the British Journal of Ophthalmology has demonstrated that prematurely born children have a thicker central macular than children born at term.

Professor Gerd Holmström et al., Department of Ophthalmology, University Hospital, Sweden, studied 65 prematurely born children between the ages of 5–16 years and 55 children born at term with Stratus optical coherence tomography (OCT). The foveal minimum, total macular volume and retinal macular thickness in nine macular areas were evaluated.

There was no correlation between macular thickness and refraction or visual acuity. It was found that children with previous retinopathy of prematurity (ROP) had a thicker macular than those who didn't. Children born without ROP still had a thicker macular than the control group. The results revealed that prematurity highly influences central macular thickness and is the most significant risk factor for abnormal foeval development.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
© 2025 MJH Life Sciences

All rights reserved.